Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 1
2021 10
2022 10
2023 12
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean bernier a (295 results)?
Post-acute COVID-19 syndrome.
Montani D, Savale L, Noel N, Meyrignac O, Colle R, Gasnier M, Corruble E, Beurnier A, Jutant EM, Pham T, Lecoq AL, Papon JF, Figueiredo S, Harrois A, Humbert M, Monnet X; COMEBAC Study Group. Montani D, et al. Among authors: beurnier a. Eur Respir Rev. 2022 Mar 9;31(163):210185. doi: 10.1183/16000617.0185-2021. Print 2022 Mar 31. Eur Respir Rev. 2022. PMID: 35264409 Free PMC article. Review.
Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study.
Menzies-Gow A, Wechsler ME, Brightling CE, Korn S, Corren J, Israel E, Chupp G, Bednarczyk A, Ponnarambil S, Caveney S, Almqvist G, Gołąbek M, Simonsson L, Lawson K, Bowen K, Colice G; DESTINATION study investigators. Menzies-Gow A, et al. Lancet Respir Med. 2023 May;11(5):425-438. doi: 10.1016/S2213-2600(22)00492-1. Epub 2023 Jan 23. Lancet Respir Med. 2023. PMID: 36702146 Clinical Trial.
Asthma and COVID-19: an update.
Adir Y, Saliba W, Beurnier A, Humbert M. Adir Y, et al. Among authors: beurnier a. Eur Respir Rev. 2021 Dec 15;30(162):210152. doi: 10.1183/16000617.0152-2021. Print 2021 Dec 31. Eur Respir Rev. 2021. PMID: 34911694 Free PMC article. Review.
Association between Initial Treatment Strategy and Long-Term Survival in Pulmonary Arterial Hypertension.
Boucly A, Savale L, Jaïs X, Bauer F, Bergot E, Bertoletti L, Beurnier A, Bourdin A, Bouvaist H, Bulifon S, Chabanne C, Chaouat A, Cottin V, Dauphin C, Degano B, De Groote P, Favrolt N, Feng Y, Horeau-Langlard D, Jevnikar M, Jutant EM, Liang Z, Magro P, Mauran P, Moceri P, Mornex JF, Palat S, Parent F, Picard F, Pichon J, Poubeau P, Prévot G, Renard S, Reynaud-Gaubert M, Riou M, Roblot P, Sanchez O, Seferian A, Tromeur C, Weatherald J, Simonneau G, Montani D, Humbert M, Sitbon O. Boucly A, et al. Among authors: beurnier a. Am J Respir Crit Care Med. 2021 Oct 1;204(7):842-854. doi: 10.1164/rccm.202009-3698OC. Am J Respir Crit Care Med. 2021. PMID: 34185620 Free article.
[Post-COVID-19 syndrome].
Montani D, Savale L, Noel N, Meyrignac O, Colle R, Gasnier M, Corruble E, Beurnier A, Jutant EM, Pham T, Lecoq AL, Papon JF, Figuereido S, Harrois A, Humbert M, Monnet X; pour le Groupe d’étude Comebac. Montani D, et al. Among authors: beurnier a. Bull Acad Natl Med. 2023 Jun;207(6):812-820. doi: 10.1016/j.banm.2023.01.029. Epub 2023 Apr 25. Bull Acad Natl Med. 2023. PMID: 37292432 Free PMC article. Review. French.
Serum and Pulmonary Expression Profiles of the Activin Signaling System in Pulmonary Arterial Hypertension.
Guignabert C, Savale L, Boucly A, Thuillet R, Tu L, Ottaviani M, Rhodes CJ, De Groote P, Prévot G, Bergot E, Bourdin A, Howard LS, Fadel E, Beurnier A, Roche A, Jevnikar M, Jaïs X, Montani D, Wilkins MR, Sitbon O, Humbert M. Guignabert C, et al. Among authors: beurnier a. Circulation. 2023 Jun 13;147(24):1809-1822. doi: 10.1161/CIRCULATIONAHA.122.061501. Epub 2023 Apr 25. Circulation. 2023. PMID: 37096577
Functional respiratory complaints among COVID-19 survivors: a prospective cohort study.
Beurnier A, Savale L, Jaïs X, Colle R, Pham T, Morin L, Bulifon S, Noël N, Boucly A, Delbarre B, Ebstein N, Figueiredo S, Gasnier M, Harrois A, Jutant EM, Jevnikar M, Keddache S, Lecoq AL, Meyrignac O, Parent F, Pichon J, Preda M, Roche A, Seferian A, Bellin MF, Gille T, Corruble E, Sitbon O, Becquemont L, Monnet X, Humbert M, Montani D; and the Comebac Investigators; Comebac Investigators. Beurnier A, et al. ERJ Open Res. 2023 May 2;9(3):00063-2023. doi: 10.1183/23120541.00063-2023. eCollection 2023 Jul. ERJ Open Res. 2023. PMID: 37131523 Free PMC article.
Diagnosis and management of pulmonary veno-occlusive disease.
Solinas S, Boucly A, Beurnier A, Kularatne M, Grynblat J, Eyries M, Dorfmüller P, Sitbon O, Humbert M, Montani D. Solinas S, et al. Among authors: beurnier a. Expert Rev Respir Med. 2023 Jul-Dec;17(8):635-649. doi: 10.1080/17476348.2023.2247989. Epub 2023 Aug 21. Expert Rev Respir Med. 2023. PMID: 37578057 Review.
Sequential multimodal therapy in chronic thromboembolic pulmonary hypertension with mixed anatomical lesions: a proof of concept.
Jevnikar M, Solinas S, Brenot P, Lechartier B, Kularatne M, Montani D, Savale L, Garcia-Alonso C, Sitbon O, Beurnier A, Boucly A, Bulifon S, Seferian A, Roche A, Mercier O, Simonneau G, Fadel E, Humbert M, Jaïs X. Jevnikar M, et al. Among authors: beurnier a. Eur Respir J. 2023 Nov 2;62(5):2300517. doi: 10.1183/13993003.00517-2023. Print 2023 Nov. Eur Respir J. 2023. PMID: 37802632 No abstract available.
Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19.
Writing Committee for the COMEBAC Study Group; Morin L, Savale L, Pham T, Colle R, Figueiredo S, Harrois A, Gasnier M, Lecoq AL, Meyrignac O, Noel N, Baudry E, Bellin MF, Beurnier A, Choucha W, Corruble E, Dortet L, Hardy-Leger I, Radiguer F, Sportouch S, Verny C, Wyplosz B, Zaidan M, Becquemont L, Montani D, Monnet X. Writing Committee for the COMEBAC Study Group, et al. Among authors: beurnier a. JAMA. 2021 Apr 20;325(15):1525-1534. doi: 10.1001/jama.2021.3331. JAMA. 2021. PMID: 33729425 Free PMC article.
38 results